• OPEN AN ACCOUNT
Indian Indices
Nifty
25,112.40 319.15
(1.29%)
Sensex
82,408.17 1,046.30
( 1.29%)
Bank Nifty
56,252.85 675.40
( 1.22%)
Nifty IT
38,991.45 326.50
( 0.84%)
Global Indices
Nasdaq
42,197.27 -39.54
(-0.09%)
Dow Jones
6,001.75 -1.97
(-0.03%)
Hang Seng
38,498.24 9.90
(0.03%)
Nikkei 225
8,791.80 -51.67
(-0.58%)
Forex
USD-INR
86.44 0.19
(0.22%)
EUR-INR
99.39 -0.08
(-0.08%)
GBP-INR
116.19 -0.40
(-0.35%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
177.81
39.69
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

camex ltd
BCL Enterprises reports standalone net profit of Rs 0.01 crore in the March 2025 quarter
May 29,2025
Net profit of BCL Enterprises reported to Rs 0.01 crore in the quarter ended March 2025 as against net loss of Rs 3.29 crore during the previous quarter ended March 2024. Sales declined 4.35% to Rs 0.66 crore in the quarter ended March 2025 as against Rs 0.69 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 0.70 crore in the year ended March 2025 as against net loss of Rs 2.56 crore during the previous year ended March 2024. Sales rose 154.96% to Rs 6.68 crore in the year ended March 2025 as against Rs 2.62 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.660.69 -4 6.682.62 155
OPM %-40.91-491.30 -10.03-96.56 -
PBDT-0.24-3.39 93 0.77-2.53 LP
PBT-0.25-3.40 93 0.74-2.56 LP
NP0.01-3.29 LP 0.70-2.56 LP